Primary: Urinary infections including urosepsis
Empiric therapy of severely ill patients with suspected Gram-negative infections (including Pseudomonas)
Does not cover Gram-positives, anaerobes or atypical microbes
Increased nephrotoxicity
Increased ototoxicity
Neuromuscular blockade agents - Respiratory paralysis.
Formal audiology assessment if planning to use aminoglycoside for 14 days or if symptoms develop.
Inform patient of risk of ototoxicity and to report any symptoms immediately.
Antimicrobial class: Aminoglycoside
Pregnancy category: D
Average serum half life: 3 hours
Biliary penetration: Moderate
CSF penetration: Poor
Lung penetration: Therapeutic
Urine penetration: Therapeutic